{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T07:52:22Z","timestamp":1787212342331,"version":"build-2736575974"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ijcard.2024.132417","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:58:22Z","timestamp":1722646702000},"page":"132417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study"],"prefix":"10.1016","volume":"414","author":[{"given":"Jieni","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feidan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijcard.2024.132417_bb0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0039-1683416","article-title":"Epidemiology and clinical manifestations of immune thrombocytopenia","volume":"39","author":"Kohli","year":"2019","journal-title":"Hamostaseologie"},{"issue":"9","key":"10.1016\/j.ijcard.2024.132417_bb0015","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"Piel-Julian","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2010.08418.x","article-title":"Severinsen, Malene Cramer Engebjerg et al. risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study","volume":"152","author":"Marianne","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132417_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.24234","article-title":"Is ITP a thrombophilic disorder?","volume":"91","author":"Rodeghiero","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132417_bb0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.17390","article-title":"Thrombosis in immune thrombocytopenia - current status and future perspectives","volume":"194","author":"Swan","year":"2021","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12185-010-0636-3","article-title":"Comorbidities in patients with persistent or chronic immune thrombocytopenia","volume":"92","author":"Enger","year":"2010","journal-title":"Int. J. Hematol."},{"issue":"7","key":"10.1016\/j.ijcard.2024.132417_bb0040","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica-the Hematology Journal."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132417_bb0045","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/imj.14269","article-title":"Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study","volume":"49","author":"Le Guenno","year":"2019","journal-title":"Intern. Med. J."},{"issue":"8","key":"10.1016\/j.ijcard.2024.132417_bb0050","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/jth.12636","article-title":"Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors","volume":"12","author":"Ruggeri","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132417_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00277-019-03886-6","article-title":"Evaluation of thrombotic events in patients with immune thrombocytopenia","volume":"99","author":"Ito","year":"2020","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.13787","article-title":"Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study","volume":"174","author":"N\u00f8rgaard","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijcard.2024.132417_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jclinepi.2022.06.022","article-title":"A gentle introduction to instrumental variables","volume":"149","author":"Widding-Havneraas","year":"2022","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132417_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","article-title":"Guidelines for performing Mendelian randomization investigations: update for summer 2023","volume":"4","author":"Burgess","year":"2023","journal-title":"Wellcome Open Res."},{"issue":"16","key":"10.1016\/j.ijcard.2024.132417_bb0080","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"7944","key":"10.1016\/j.ijcard.2024.132417_bb0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat. Methods Med. Res."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0095","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.ijcard.2024.132417_bb0100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10654-015-0011-z","article-title":"Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors","volume":"30","author":"Burgess","year":"2015","journal-title":"Eur. J. Epidemiol."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0105","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet. Epidemiol."},{"issue":"5","key":"10.1016\/j.ijcard.2024.132417_bb0115","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.ijcard.2024.132417_bb0120","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMe2110953","article-title":"Orcid id. Immune thrombocytopenia treatment","volume":"385","author":"Bolton-Maggs","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0125","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2003-11-3908","article-title":"Long-term outcomes in adults with chronic ITP after splenectomy failure","volume":"104","author":"McMillan","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.11.026","article-title":"A case of multiple cerebral infarction preceding acute exacerbation of idiopathic thrombocytopenic Purpura","volume":"28","author":"Sasaki","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"14","key":"10.1016\/j.ijcard.2024.132417_bb0135","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.2147\/IJGM.S323146","article-title":"Pulmonary thromboembolism in immune thrombocytopenia: a report of five cases and a review of the literature","volume":"13","author":"Tan","year":"2021","journal-title":"Int J Gen Med."},{"key":"10.1016\/j.ijcard.2024.132417_bb0140","first-page":"6738348","article-title":"Recurrent acute coronary syndromes in a patient with idiopathic thrombocytopenic Purpura","volume":"2020","author":"Iakovis","year":"2020","journal-title":"Case Rep. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132417_bb0145","article-title":"Management of Recurrent Venous Thromboembolism in severe immune thrombocytopenia: a case report and a review of the literature","author":"Nielsen","year":"2023","journal-title":"Hamostaseologie"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.13787","article-title":"Risk of arterial thrombotic and venous thromboembolic events in patients with primary chronic immune thrombocytopenia: a Scandinavian population-based cohort study","volume":"174","author":"N\u00f8rgaard","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.ijcard.2024.132417_bb0155","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2010.08418.x","article-title":"Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study","volume":"152","author":"Severinsen","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132417_bb0160","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/imj.14269","article-title":"Characteristics, risk factors and management of venous thromboembolism in immune thrombocytopenia: a retrospective multicentre study","volume":"49","author":"Le Guenno","year":"2019","journal-title":"Intern. Med. J."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132417_bb0165","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood-2017-09-742353","article-title":"Splenectomy for immune thrombocytopenia: down but not out","volume":"131","author":"Chaturvedi","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132417_bb0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2141.2012.09146.x","article-title":"Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?","volume":"158","author":"Rodeghiero","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132417_bb0175","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1046\/j.1365-2168.2000.01514.x","article-title":"Diagnosis and treatment of portal vein thrombosis following splenectomy","volume":"87","author":"van\u2019t Riet M, Burger JW, van Muiswinkel JM, Kazemier G, Schipperus MR, Bonjer HJ.","year":"2000","journal-title":"Br. J. Surg."},{"issue":"23","key":"10.1016\/j.ijcard.2024.132417_bb0180","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1182\/blood-2012-12-467068","article-title":"Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia","volume":"121","author":"Boyle","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1182\/blood-2015-05-647552","article-title":"Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy","volume":"127","author":"Ammann","year":"2016","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ijcard.2024.132417_bb0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamainternmed.2013.122","article-title":"Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study","volume":"173","author":"Johannesdottir","year":"2013","journal-title":"JAMA Intern. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0195","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11739-007-0026-X","article-title":"The coagulation system in endocrine disorders: a narrative review","volume":"2","author":"Squizzato","year":"2007","journal-title":"Intern. Emerg. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132417_bb0200","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1111\/j.1538-7836.2010.04034.x","article-title":"Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors","volume":"8","author":"van Zaane","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.thromres.2005.06.006","article-title":"Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers","volume":"118","author":"Brotman","year":"2006","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.ijcard.2024.132417_bb0210","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom general practice research database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12777","article-title":"Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis","volume":"97","author":"Doobaree","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ijcard.2024.132417_bb0220","article-title":"Arterial and venous thromboses in patients with idiopathic (immunological) thrombocytopenia: a possible contributing role of cortisone-induced hypercoagulable state","volume":"Nov-Dec;19(6):613-18","author":"Girolami","year":"2013","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132417_bb0225","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1038\/s41598-017-03668-y","article-title":"Evaluation of the immature platelet fraction contribute to the differential diagnosis of hereditary, immune and other acquired thrombocytopenias","volume":"7","author":"Ferreira","year":"2017","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.ijcard.2024.132417_bb0230","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.ijcard.2024.132417_bb0235","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132417_bb0240","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1002\/ajh.24526","article-title":"Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia","volume":"91","author":"Khanal","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132417_bb0245","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11239-017-1478-0","article-title":"Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study","volume":"43","author":"Mantha","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"issue":"25","key":"10.1016\/j.ijcard.2024.132417_bb0250","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1182\/blood-2018-08-868406","article-title":"Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score","volume":"132","author":"Balitsky","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132417_bb0255","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00277-014-2198-6","article-title":"Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study","volume":"94","author":"Kopolovic","year":"2015","journal-title":"Ann. Hematol."},{"issue":"2013","key":"10.1016\/j.ijcard.2024.132417_bb0260","article-title":"Two cases and review of the literature: primary percutaneous angiography and antiplatelet management in patients with immune thrombocytopenic purpura","volume":"29","author":"Torbey","year":"2013","journal-title":"ISRN Hematol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324010398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324010398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T21:09:11Z","timestamp":1737925751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324010398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":52,"alternative-id":["S0167527324010398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132417","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune thrombocytopenia increases the risk of thrombosis: A two-sample Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132417"}}